Clinical Report: Impact of Nd: YAG Laser Capsulotomy on Central Macular Thickness
Overview
This systematic review and meta-analysis evaluated changes in central macular thickness (CMT) following Nd: YAG laser capsulotomy for posterior capsule opacification (PCO). Significant increases in CMT were observed at postoperative week 1, month 1, and month 3, with no change at day 1.
Background
Posterior capsule opacification (PCO) is a common complication after cataract surgery, affecting visual acuity. Nd: YAG laser capsulotomy is the standard treatment for PCO, but it carries risks of complications, including cystoid macular edema (CME).
Data Highlights
Time Point
Mean Difference (MD) μm
p-value
I²
Day 1
0.06
0.97
0%
Week 1
8.72
< 0.001
85%
Month 1
3.69
< 0.001
12%
Month 3
5.07
< 0.001
0%
Key Findings
Significant increase in CMT at week 1 (MD: 8.72 μm; p < 0.001).
No significant change in CMT at day 1 (MD: 0.06 μm; p = 0.97).
At month 1, CMT increased by 3.69 μm (p < 0.001).
At month 3, CMT increased by 5.07 μm (p < 0.001).
Greater CMT changes at week 1 were associated with laser energy ≥ 50 mJ and baseline BCVA ≥ 0.5 logMAR.
No significant associations found in meta-regression for ethnicity, study design, steroid use, or sample size.
Clinical Implications
Monitoring CMT in the postoperative period is necessary.
Conclusion
This meta-analysis provides evidence of significant CMT changes following Nd: YAG laser capsulotomy.
At ASRS 2026, Dilsher S. Dhoot, MD, FASRS, shared additional phase 3 SOL-1 data on vision maintenance, rescue treatment, and safety with investigational OTX-TKI (Axpaxli) in neovascular AMD.
At OIS Retina in Montreal, Riad Sherif, MD, discussed Oculis’s optic neuritis program and why neuroprotection may represent the next frontier in retinal therapeutics.
